Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

AZD-6280

Generic Name: AZD-6280

Drug Type: Small Molecule

Chemical Formula: C_₂₀H_₂₂N_₄O_₃

CAS Number: 942436-93-3

Unique Ingredient Identifier: B9Z1OEH19D

Overview

AZD6280 has been used in trials studying the basic science of Anxiety.

Background

AZD6280 has been used in trials studying the basic science of Anxiety.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Effect of Multiple Doses of AZD6280 on the Pharmacokinetics of Midazolam (CYP3A4) and Caffeine (CYP1A2)

Phase 1

Completed

Posted: 2009/01/16

Sponsor:AstraZeneca

ID:NCT00824057

A Sedation/Cognition/EEG Study Using AZD6280 and Comparator

Phase 1

Completed

Posted: 2008/09/11

Sponsor:AstraZeneca

ID:NCT00750802

Positron Emission Tomography (PET) Study With (11C) Flumazenil to Determine Central GABAA Receptor Occupancy of AZD6280

Phase 1

Completed

Posted: 2008/05/21

Sponsor:AstraZeneca

ID:NCT00681746

AZD6280 Multiple Ascending Dose Study

Phase 1

Completed

Posted: 2008/05/21

Sponsor:AstraZeneca

ID:NCT00681317

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy